Eikon Therapeutics Inc (EIKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | 12-2024 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 161,554 | 105,301 | 0 | 129,579 |
| Marketable Securities | 351,028 | 231,074 | 0 | 90,932 |
| Other current assets | 0 | 0 | 0 | 7,378 |
| TOTAL | $529,501 | $348,917 | $0 | $227,889 |
| Non-Current Assets | ||||
| PPE Net | 138,067 | 142,898 | N/A | 174,581 |
| Investments And Advances | 83,828 | 0 | 0 | 0 |
| Other Non-Current Assets | 99,430 | 102,919 | 0 | 4,219 |
| TOTAL | $321,325 | $245,817 | $N/A | $178,800 |
| Total Assets | $850,826 | $594,734 | $0 | $491,240 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 6,005 | 681 | 0 | 17,578 |
| Accrued Expenses | 29,319 | 44,298 | 0 | 29,564 |
| TOTAL | $45,064 | $55,007 | $0 | $56,449 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 255,091 | 1,418,761 | 0 | 813,569 |
| TOTAL | $255,091 | $1,418,761 | $N/A | $813,569 |
| Total Liabilities | $300,155 | $1,473,768 | $0 | $1,063,170 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 54,139 | N/A | N/A | N/A |
| Common Shares | 5 | N/A | 0 | 0 |
| Retained earnings | -1,003,467 | -920,509 | 0 | -604,941 |
| TOTAL | $550,671 | $-879,034 | $0 | $-571,930 |
| Total Liabilities And Equity | $850,826 | $594,734 | $0 | $491,240 |